BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3243042)

  • 1. Pharmacokinetics of theophylline and its metabolites in a patient undergoing continuous ambulatory peritoneal dialysis.
    Vree TB; Martea M; Tiggeler RG; Hekster YA; Hafkenscheid JC
    Clin Pharmacokinet; 1988 Dec; 15(6):390-5. PubMed ID: 3243042
    [No Abstract]   [Full Text] [Related]  

  • 2. Lack of effect of terfenadine on theophylline pharmacokinetics and metabolism in normal subjects.
    Brion N; Naline E; Beaumont D; Pays M; Advenier C
    Br J Clin Pharmacol; 1989 Mar; 27(3):391-5. PubMed ID: 2497767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Theophylline toxicity risks and chronic renal failure.
    Nicot G; Charmes JP; Lachatre G; Sautereau D; Valette JP; Eichler B; Leroux-Robert C
    Int J Clin Pharmacol Ther Toxicol; 1989 Aug; 27(8):398-401. PubMed ID: 2793275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of urinary metabolites of theophylline to serum theophylline levels.
    Jenne JW; Nagasawa HT; Thompson RD
    Clin Pharmacol Ther; 1976 Mar; 19(3):375-81. PubMed ID: 1261172
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacokinetics of theophylline metabolites in 8 Chinese patients.
    Cao W; Zhuo HT; Chen G; Ling SS
    Zhongguo Yao Li Xue Bao; 1998 Sep; 19(5):437-9. PubMed ID: 10375804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of theophylline and its metabolites during acute renal failure. A case report.
    Leakey TE; Elias-Jones AC; Coates PE; Smith KJ
    Clin Pharmacokinet; 1991 Nov; 21(5):400-8. PubMed ID: 1773552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The theophylline-enoxacin interaction: I. Effect of enoxacin dose size on theophylline disposition.
    Rogge MC; Solomon WR; Sedman AJ; Welling PG; Toothaker RD; Wagner JG
    Clin Pharmacol Ther; 1988 Nov; 44(5):579-87. PubMed ID: 3180639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Theophylline metabolism affected by mexiletine.
    Rost KL; Fuhr U; Roots I; Staib AH
    Clin Pharmacol Ther; 1992 Jul; 52(1):107-9. PubMed ID: 1623687
    [No Abstract]   [Full Text] [Related]  

  • 9. High-throughput liquid chromatography-tandem mass spectrometry assay for plasma theophylline and its metabolites.
    Song J; Park KU; Park HD; Yoon Y; Kim JQ
    Clin Chem; 2004 Nov; 50(11):2176-9. PubMed ID: 15502093
    [No Abstract]   [Full Text] [Related]  

  • 10. Lack of effect of olanzapine on the pharmacokinetics of a single aminophylline dose in healthy men.
    Macias WL; Bergstrom RF; Cerimele BJ; Kassahun K; Tatum DE; Callaghan JT
    Pharmacotherapy; 1998; 18(6):1237-48. PubMed ID: 9855322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Peculiarities of the pharmacokinetics and pharmacodynamics of theophylline in children].
    Berdel D; Heimann G
    Wien Klin Wochenschr; 1984 Aug; 96(16):616-21. PubMed ID: 6516414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Theophylline-induced increase in plasma uric acid--purine catabolism increased by theophylline.
    Yamamoto T; Moriwaki Y; Suda M; Takahashi S; Hiroishi K; Higashino K
    Int J Clin Pharmacol Ther Toxicol; 1991 Jul; 29(7):257-61. PubMed ID: 1889911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1-Methylxanthine derived from theophylline as an in vivo biochemical probe of allopurinol effect.
    Birkett DJ; Miners JO; Day RO
    Br J Clin Pharmacol; 1991 Aug; 32(2):238-41. PubMed ID: 1931474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurotoxic convulsions induced by theophylline and its metabolites in mice.
    Yamamoto K; Toyama E; Kawakami J; Sawada Y; Iga T
    Biol Pharm Bull; 1996 Jun; 19(6):869-72. PubMed ID: 8799489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Determination of theophylline in the plasma by rapid solid-phase extraction].
    Bompadre S; Ercolani P; Leone L
    Boll Soc Ital Biol Sper; 1987 Aug; 63(8):717-23. PubMed ID: 3663373
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasma concentrations of theophylline and its metabolites in a theophylline intoxicated child--reevaluation of published Km-values.
    Gundert-Remy U; Krüdewagen B; Hildebrandt R
    Br J Clin Pharmacol; 1986 Nov; 22(5):617-8. PubMed ID: 3790410
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pharmacokinetics of cefotiam in patients undergoing continuous ambulatory peritoneal dialysis].
    Itagaki N; Hasegawa H; Tsujino M; Takahashi K; Yamamoto Y; Imada A; Horiuchi A
    Jpn J Antibiot; 1988 Apr; 41(4):405-8. PubMed ID: 3165474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Factors affecting transperitoneal calcium flux in patients undergoing continuous ambulatory peritoneal dialysis].
    Shigematsu T; Nakayama M; Yokoyama K; Kawaguchi Y; Kubo H; Watanabe S; Aizawa S; Kameda C; Miyahara T
    Nihon Jinzo Gakkai Shi; 1988 Aug; 30(8):955-62. PubMed ID: 3244191
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacokinetics of theophylline in diabetes mellitus rats: induction of CYP1A2 and CYP2E1 on 1,3-dimethyluric acid formation.
    Kim YC; Lee AK; Lee JH; Lee I; Lee DC; Kim SH; Kim SG; Lee MG
    Eur J Pharm Sci; 2005 Sep; 26(1):114-23. PubMed ID: 15985363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a sensitive LC-MS/MS method for the simultaneous quantitation of theophylline and its metabolites in rat plasma.
    Chae JW; Kim DH; Lee BY; Kim Ej; Kwon KI
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Mar; 889-890():44-9. PubMed ID: 22365533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.